NCT06572319
- Conditions
- HER2-positive Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
Clinical trial condition
HER2-positive Gastroesophageal Junction Adenocarcinoma
Explore clinical trials studying HER2-positive Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
HER2-positive Gastroesophageal Junction Adenocarcinoma trial results
NCT05993234
- Conditions
- HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma
- Locations
-
- Ordensklinikum Linz GmbH Barmherzige Schwestern Linz, Austria
- Medizinische Universität Wien Vienna, Austria
- Kepler Universitätsklinikum Wels, Austria
- Landesklinikum Wiener Neustadt Wiener Neustadt, Austria